沪深市场个股详情
688247 宣泰医药
- 12.30
- -0.28-2.23%
已收盘 11/12 15:00 (北京)
55.76亿总市值50.83市盈率TTM
12.83最高价12.16最低价10.37万手成交量12.49今开12.58昨收1.30亿成交额7.29%换手率91.11市盈率(静)4.53亿总股本12.9052周最高4.51市净率17.51亿流通值6.2352周最低15.10涨停价1.42亿流通股27.87历史最高10.06跌停价5.33%振幅6.23历史最低0.07股息TTM12.50平均价5.66万手内盘0.54%股息率TTM100股每手4.28万手外盘
宣泰医药关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 69.95%3.63亿 | 96.81%2.18亿 | 162.65%1.11亿 | 21.13%3亿 | 14.16%2.13亿 | -13.37%1.11亿 | -32.86%4,241.83万 | -21.53%2.48亿 | -19.15%1.87亿 | -18.13%1.28亿 |
| 营业收入 | 69.95%3.63亿 | 96.81%2.18亿 | 162.65%1.11亿 | 21.13%3亿 | 14.16%2.13亿 | -13.37%1.11亿 | -32.86%4,241.83万 | -21.53%2.48亿 | -19.15%1.87亿 | -18.13%1.28亿 |
| 营业总成本 | 52.82%2.66亿 | 78.56%1.65亿 | 118.91%8,555.64万 | 34.11%2.46亿 | 38.79%1.74亿 | 3.65%9,222.79万 | -7.97%3,908.33万 | -17.35%1.83亿 | -23.34%1.26亿 | -19.79%8,897.93万 |
| 营业成本 | 67.80%1.77亿 | 123.11%1.11亿 | 227.41%6,077.39万 | 85.70%1.32亿 | 113.16%1.05亿 | 42.49%4,988.48万 | 31.39%1,856.19万 | 3.22%7,122.64万 | -5.22%4,943.43万 | 30.15%3,500.85万 |
| 营业税金及附加 | 228.54%199.64万 | 215.10%116.89万 | 226.27%57.67万 | 289.96%303.16万 | 9.16%60.76万 | 4.53%37.1万 | 1.42%17.68万 | 0.42%77.74万 | -55.62%55.67万 | -68.20%35.49万 |
| 销售费用 | 22.03%683.67万 | 17.44%452.51万 | 61.07%219.46万 | 33.86%817.37万 | 30.09%560.24万 | 24.33%385.31万 | 3.70%136.25万 | 1.61%610.63万 | -8.56%430.67万 | -9.49%309.91万 |
| 管理费用 | 6.05%2,771.66万 | 5.64%1,750.3万 | 5.19%784.21万 | -5.38%3,575.7万 | -4.90%2,613.55万 | -16.68%1,656.91万 | -13.47%745.51万 | -4.82%3,778.9万 | -12.60%2,748.28万 | -16.40%1,988.67万 |
| 财务费用 | 50.00%-338.54万 | 35.96%-387.88万 | -300.17%-128.53万 | 14.78%-724.06万 | 10.40%-677.16万 | -29.84%-605.7万 | 274.66%64.21万 | -401.31%-849.66万 | -595.34%-755.73万 | -280.47%-466.49万 |
| -利息费用 | -93.98%2,208.77 | -95.29%1,666.2 | -95.06%928.65 | -82.29%3.78万 | -76.68%3.67万 | -67.02%3.54万 | -65.64%1.88万 | -7.04%21.35万 | -0.41%15.73万 | 3.61%10.73万 |
| -利息收入 | 39.64%-320.18万 | 51.20%-228.02万 | -118.33%-108.58万 | -87.55%-607.78万 | -170.12%-530.42万 | -237.33%-467.21万 | 33.97%-49.73万 | -119.20%-324.07万 | -80.65%-196.36万 | -107.77%-138.5万 |
| 研发费用 | 30.08%5,647.17万 | 23.39%3,406.41万 | 41.98%1,545.45万 | -2.65%7,400.54万 | -15.56%4,341.37万 | -21.78%2,760.69万 | -41.50%1,088.5万 | -26.64%7,602.05万 | -29.38%5,141.13万 | -33.56%3,529.51万 |
| 信用减值损失 | -722.69%-342.07万 | -165.34%-84.24万 | -124.63%-39.9万 | 43.52%-80.59万 | 148.38%54.93万 | 254.00%128.93万 | 367.19%161.98万 | -595.11%-142.69万 | -527.50%-113.55万 | -181.57%-83.72万 |
| 资产减值损失 | 110.40%12.28万 | -14.61%-102.13万 | 83.70%-6.4万 | -159.22%-153.15万 | -994.78%-118.13万 | -416.68%-89.1万 | -277.37%-39.27万 | 347.95%258.6万 | 118.66%13.2万 | 55.67%-17.25万 |
| 非经营性净收益 | ||||||||||
| 投资净收益 | -6.99%699.51万 | 21.20%635.64万 | -63.58%100.68万 | -47.80%1,136.91万 | -19.62%752.06万 | -1.93%524.47万 | 1.82%276.41万 | 421.27%2,177.98万 | 740.05%935.61万 | 2,698.08%534.77万 |
| -其中:对联营合营企业的投资收益 | -75.70%18.74万 | 312.79%146.7万 | -440.33%-37.09万 | -148.29%-213.79万 | -80.96%77.12万 | -84.36%35.54万 | -93.19%10.9万 | 726.69%442.75万 | 498.61%404.93万 | 381.30%227.27万 |
| 资产处置收益 | ---- | ---- | ---- | -47.20%8.21万 | --8.21万 | --4.01万 | ---- | --15.55万 | ---- | ---- |
| 其他收益 | 52.09%292.04万 | 129.26%173.97万 | -62.00%18.9万 | -49.41%601.87万 | -48.66%192.02万 | -62.32%75.88万 | 20.45%49.75万 | -50.22%1,189.78万 | 265.45%374.03万 | 199.18%201.4万 |
| 营业利润 | 114.58%1.03亿 | 138.39%5,954.83万 | 239.84%2,658.8万 | -30.38%6,901.18万 | -34.72%4,789.2万 | -44.77%2,497.94万 | -66.64%782.37万 | -18.28%9,913.16万 | 5.64%7,336.22万 | -4.21%4,522.59万 |
| 加:营业外收入 | -94.72%5,549.16 | -99.18%824.78 | -33.18%128.32 | 3,949.87%12.81万 | 4,783.20%10.51万 | 18,322.17%10.11万 | 1,920,400.00%192.05 | -99.99%3,163.96 | -71.93%2,153.26 | -88.46%548.84 |
| 减:营业外支出 | 637.41%83.61万 | 1,035.24%29.21万 | --18.45万 | 89.78%314.91万 | -87.08%11.34万 | -97.07%2.57万 | ---- | -68.73%165.94万 | -75.90%87.72万 | -68.57%87.72万 |
| 利润总额 | 112.89%1.02亿 | 136.51%5,925.7万 | 237.47%2,640.36万 | -32.30%6,599.08万 | -33.94%4,788.38万 | -43.51%2,505.48万 | -65.47%782.39万 | -34.59%9,747.54万 | 10.14%7,248.71万 | -0.18%4,434.92万 |
| 减:所得税费用 | 146.35%936.45万 | 125.57%510.37万 | 3,172.12%350.77万 | 8.21%491.67万 | -29.40%380.13万 | -45.41%226.26万 | -95.52%10.72万 | -67.77%454.38万 | 11.67%538.45万 | -44.60%414.5万 |
| 净利润 | 110.00%9,257.3万 | 137.60%5,415.33万 | 196.71%2,289.59万 | -34.28%6,107.41万 | -34.31%4,408.25万 | -43.31%2,279.22万 | -61.92%771.67万 | -31.12%9,293.16万 | 10.02%6,710.26万 | 8.81%4,020.42万 |
| 持续经营净利润 | 110.00%9,257.3万 | 137.60%5,415.33万 | 196.71%2,289.59万 | -34.28%6,107.41万 | -34.31%4,408.25万 | -43.31%2,279.22万 | -61.92%771.67万 | -31.12%9,293.16万 | 10.02%6,710.26万 | 8.81%4,020.42万 |
| 归属于母公司所有者的净利润 | 110.00%9,257.3万 | 137.60%5,415.33万 | 196.71%2,289.59万 | -34.28%6,107.41万 | -34.31%4,408.25万 | -43.31%2,279.22万 | -61.92%771.67万 | -31.12%9,293.16万 | 10.02%6,710.26万 | 8.81%4,020.42万 |
| 每股收益 | ||||||||||
| 基本每股收益 | 110.00%0.21 | 140.00%0.12 | 150.00%0.05 | -40.91%0.13 | -37.50%0.1 | -50.00%0.05 | -60.00%0.02 | -33.33%0.22 | 6.67%0.16 | 11.11%0.1 |
| 稀释每股收益 | 110.00%0.21 | 140.00%0.12 | 150.00%0.05 | -40.91%0.13 | -37.50%0.1 | -50.00%0.05 | -60.00%0.02 | -33.33%0.22 | 6.67%0.16 | 11.11%0.1 |
| 其他综合收益 | -80.38%1.06万 | -105.13%-3,507.81 | 99.56%-107.34 | -88.50%1.8万 | -71.74%5.4万 | -22.98%6.83万 | -231.16%-2.43万 | 460.48%15.64万 | 1,504.33%19.12万 | 533.12%8.87万 |
| 归属于母公司所有者的其他综合收益总额 | -80.38%1.06万 | -105.13%-3,507.81 | 99.56%-107.34 | -88.50%1.8万 | -71.74%5.4万 | -22.98%6.83万 | -231.16%-2.43万 | 460.48%15.64万 | 1,504.33%19.12万 | 533.12%8.87万 |
| 综合收益总额 | 109.77%9,258.36万 | 136.87%5,414.98万 | 197.64%2,289.58万 | -34.37%6,109.2万 | -34.41%4,413.66万 | -43.26%2,286.05万 | -62.02%769.24万 | -30.98%9,308.79万 | 10.36%6,729.39万 | 9.11%4,029.3万 |
| 归属于母公司所有者的综合收益总额 | 109.77%9,258.36万 | 136.87%5,414.98万 | 197.64%2,289.58万 | -34.37%6,109.2万 | -34.41%4,413.66万 | -43.26%2,286.05万 | -62.02%769.24万 | -30.98%9,308.79万 | 10.36%6,729.39万 | 9.11%4,029.3万 |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | -- | -- | -- |
| 会计师事务所 | -- | -- | -- | 上会会计师事务所(特殊普通合伙) | -- | -- | -- | 上会会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。
分析
目标价预测
暂无数据
热议
沪深
综合热度
股票代码
最新价
涨跌幅
暂无数据